Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this project is to quantify the relative effectiveness of aerobic exercise monitored by smart wristbands in assisting the treatment of depression and improving cognitive function. It aims to explore the mechanisms through which aerobic exercise exerts its effects using imaging genetics and other methods, and to identify suitable populations for exercise, ultimately providing personalized clinical exercise prescriptions. This study will intervene from a behavioral perspective and also seeks to motivate participants to change and improve their physical activity habits.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Aerobic exercise group | Experimental | Aerobic exercise intervention combined with conventional drug treatment |
|
| Waiting control group | No Intervention | Antidepressants were routinely used and aerobic exercise interventions were performed at the end of the 8-week follow-up |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aerobic exercise | Behavioral | Moderate-intensity aerobic exercise for 30-50 minutes three times a week was added to usual medical therapy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in Hamilton Depression Rating Scale (HAMD) | The outcome is assessed by HAMD-17 Scale. | Week 4 and 8 of treatment duration |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in THINC-it score | Week 4 and 8 of treatment duration | |
| Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) | Week 4 and 8 of treatment duration | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Weihua Yue, Doctor | Contact | 86-010-82805307 | dryue@bjmu.edu.cn | |
| Guorui Zhao | Contact | 86-13661352950 | grzhao@bjmu.edu.cn |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Peking University Sixth Hostipal | Recruiting | Beijing | Beijing Municipality | 100191 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Response to treatment |
The reduction rate of HAMD-17 or MADRS score was ≥50% |
| Week 4 and 8 of treatment duration |
| Clinical Global Impression-Severity of Illness (CGI-S) | Week 4 and 8 of treatment duration |
| Change from baseline in Hamilton Anxiety Rating Scale (HAMA) | Week 4 and 8 of treatment duration |
| Change from baseline in Ruminative Responses Scale (RRS) | Week 4 and 8 of treatment duration |
| Change from baseline in Pittsburgh Sleep Quality Index (PSQI) | Week 4 and 8 of treatment duration |
| Change from baseline in Connor-Davidson Resilience Scale (CD-RISC) | Week 4 and 8 of treatment duration |
| Rating Scale for Side Effects (SERS) -Antidepressant | Rating Scale for Side Effects (SERS) -Antidepressant | Week 4 and 8 of treatment duration |
| Mood Disorder Questionnaire (MDQ) | Week 4 and 8 of treatment duration |
| International Physical Activity Questionnaire (IPAQ) | Week 4 and 8 of treatment duration |
| Biomarkers level | CRP, IL-1β, TNF-α, IL-6, IL-8, IL-10 and other immune factors, irisin, neurotrophic factor BDNF, vascular endothelial growth factor VEGF, and insulin growth factor IGF-1, NLRP3, CXCL8, CXCL3, CCL5, etc | Week 0 and 8 of treatment duration |
| Body weight in kilograms | Week 4 and 8 of treatment duration |
| Body fat rate | Week 4 and 8 of treatment duration |
| Brain imaging features | Acquisition was performed by magnetic resonance imaging | Week 0 and 8 of treatment duration |